Related Experiment Videos
Systemic lupus erythematosus in Lebanon
1Department of Internal Medicine, Faculty of Medicine, Department of Health Services Administration, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon. iuthman@aub.edu.lb
Lupus
|December 22, 1999
Summary
This study details systemic lupus erythematosus (SLE) patient characteristics in Lebanon. Findings show high rates of arthritis, malar rash, and renal involvement, with unique differences compared to other Arab SLE cohorts.
Area of Science:
- Rheumatology
- Immunology
- Internal Medicine
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical presentations.
- Understanding regional variations in SLE manifestations is crucial for accurate diagnosis and management.
- The American University of Beirut Medical Center (AUBMC) serves a diverse patient population in Lebanon.
Purpose of the Study:
- To describe the clinical and serological characteristics of SLE patients at AUBMC, Lebanon.
- To compare these findings with other SLE cohorts in Arab countries.
- To identify potential demographic and clinical differences in SLE presentation.
Main Methods:
- Retrospective chart review of 100 SLE patients diagnosed at AUBMC over a 20-year period.
- Data collection included demographics, clinical features, hematological manifestations, and autoantibody profiles.
- Statistical comparison with published data from three other Arab SLE cohorts.
Main Results:
- The study population comprised 86 females and 14 males with a median age of 26 years.
- The most frequent clinical features were arthritis/arthralgias (95%), malar rash (52%), and renal involvement (50%).
- Hematological findings included thrombocytopenia (33%), leucopenia (17%), and hemolytic anemia (10%).
- Compared to other Arab SLE groups, AUBMC patients exhibited a higher incidence of oral ulcers, discoid lupus, articular symptoms, thrombocytopenia, and false-positive VDRL, but lower rates of photosensitivity, leucopenia, neuropsychiatric issues, and anti-DNA antibodies.
Conclusions:
- SLE in Lebanon presents with a high burden of articular and mucocutaneous manifestations.
- Distinctive clinical features, including a higher prevalence of certain symptoms and serological markers, were observed compared to other regional SLE populations.
- These findings highlight the importance of considering geographic and ethnic factors in the clinical expression of SLE.